|
시장보고서
상품코드
2067391
수막염 진단 검사 시장 : 검사 유형별, 기술별, 검체 유형별, 병원체별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)Meningitis Diagnostic Testing Market, By Test Type, By Technology, By Sample Type, By Pathogen, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
수막염 진단 검사 시장 규모는 2025년에 1억 2,898만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 3.5%로 확대될 것으로 전망됩니다.
수막염 진단 검사는 뇌와 척수를 감싸고 있는 보호층인 수막에 염증이 동반된 감염증에 환자가 걸렸는지 여부를 판단하기 위한 진단 검사를 수행하는 과정을 말합니다. 수막염 검사에는 환자에게 효과적인 치료를 제공하기 위해 이 질환을 유발하는 원인균을 규명하는 데 도움이 되는 검사가 포함됩니다. 수막염 진단의 일환으로 시행되는 검사에는 뇌척수액 검사, 혈액 배양, PCR 검사, 항원 검사, 현미경 검사, 분자생물학적 방법 등이 있습니다. 이러한 검사를 실시하는 주요 목적은 정확한 진단과 조기 의료 개입을 통해 이 질환으로 인한 악영향을 최소화하는 데 있습니다. 질병의 조기 발견과 모니터링의 중요성이 커짐에 따라, 수막염 진단 검사는 전 세계의 현대 의료 시스템과 의료 기관에서 필수적인 요소가 되고 있습니다.
수막염 진단 검사 시장 - 시장 역학
나노기술과 미세 가공 기술의 발전이 시장 수요를 견인
전 세계적으로 뇌수막염으로 진단받는 환자 수가 증가하고 있는 것은, 이 질환을 적시에 진단하고 신속히 치료해야 할 필요성 때문에 수막염 진단 검사 시장의 발전에 긍정적인 영향을 미치는 중요한 요인이 되고 있습니다. 수막염은 높은 사망률과 발병률뿐만 아니라, 이 질환으로 인해 발생하는 뇌 손상과 관련된 여러 가지 잠재적 합병증이 있기 때문에 심각한 건강 문제로 대두되고 있습니다. WHO에 따르면, 수막염은 여전히 전 세계적으로 시급한 보건 문제이며, 빈곤국과 아프리카의 ‘수막염 벨트’ 지역에서 널리 유행하고 있습니다. 몇 가지 공식 통계도 이 문제를 뒷받침하고 있습니다. 예를 들어, WHO가 발표한 보고서에 따르면 매년 약 250만 명이 뇌수막염에 감염되며, 이 중 160만 명이 세균성 뇌수막염을 앓고, 연간 24만 명이 사망하고 있습니다. 또한, 환자의 약 20%는 청각 장애, 기억 상실, 나아가 뇌 합병증 등 어떤 형태의 심각한 후유증을 앓고 있습니다. 세계보건기구(WHO)는 2030년까지의 뇌수막염 대책을 위한 세계 전략을 수립했습니다.
수막염 진단 검사 시장 - 시장 세분화 분석:
전 세계 수막염 진단 검사 시장은 검사 유형, 기술, 검체 유형, 병원체, 최종사용자 및 지역별로 세분화되어 있습니다.
검사 유형에 따라 시장은 6가지 범주로 분류됩니다. 즉, 라텍스 응집법, PCR 분석법, 측방유동 어세이법, CRISPR 기반 분석법, 배양 검사 및 ELISA 검사입니다. PCR 검사가 수막염 진단 검사 시장을 주도할 것으로 전망됩니다. 이는 수막염을 유발하는 병원체를 신속하고 정밀하며 정확하게 규명할 수 있는 능력에서 비롯된 것입니다. PCR 검사는 뇌척수액이나 뇌수막염 환자로부터 채취한 기타 검체 내에 존재하는 세균, 바이러스 또는 진균을 확인합니다. 특히, 환자가 뇌수막염으로 인한 사망 위험에 처해 있는 경우, 신속한 진단과 치료 개시를 위해 뇌수막염의 병원체를 조기에 규명할 필요성이 커지고 있습니다.
이 시장은 병원체에 따라 세균성, 진균성, 기생충성, 바이러스성 등 4가지 범주로 분류됩니다. 세균성 질환이 시장 점유율의 대부분을 차지하고 있을 가능성이 있습니다. 이러한 증가는 세균성 감염증이 환자의 건강에 미치는 중대한 영향뿐만 아니라, 정확하고 신속한 진단의 필요성과도 관련이 있는 것으로 보입니다. 세균성 뇌수막염은 사망률과 발병률 양면에서 매우 높은 위험성을 특징으로 하며, 이 질환이 진행됨에 따라 청력 상실, 뇌 손상, 지적 장애 등의 합병증이 발생할 수도 있습니다. Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae에 의한 세균 감염 사례가 크게 증가하고 있어, 이 질환을 진단하기 위한 혁신적인 기술이 요구되고 있습니다.
수막염 진단 검사 시장 - 지역별 분석
북미는 수막염 진단 검사 시장을 주도할 것으로 전망됩니다. 이러한 성장 요인으로는 우수한 의료 인프라, 분자진단 기술의 광범위한 활용, 그리고 감염병 감시에 대한 매우 집중적인 노력이 꼽힙니다. 북미는 광범위한 의료 네트워크, 첨단 임상 검사실, 그리고 의료 분야의 활발한 연구 개발 활동의 혜택을 누리고 있으며, 이러한 요소들이 뇌수막염 환자의 효율적인 진단과 관리에 기여하고 있습니다. 조기 진단의 중요성에 대한 의료진의 인식이 높아진 데다, 중합효소 연쇄 반응(PCR) 검사, 다중 분자진단 패널, 자동화 검사실과 같은 첨단 진단 검사가 이용 가능해짐에 따라, 해당 지역의 진단 검사 실시 건수가 증가하고 있습니다. 또한, CDC나 PHAC와 같은 보건 기관들이 뇌수막염 사례를 감시하고, 백신 접종 프로그램 및 질병 감시 활동을 지원하고 있는 점도 수막염 진단 검사의 수요 증가로 이어지고 있습니다.
미국 수막염 진단 검사 시장 - 국가별 분석
이 지역에서 미국이 가장 큰 시장 점유율을 차지하고 있을 가능성이 있습니다. 이 분야의 성장은 지속적인 기술 발전에 힘입어 이루어지고 있습니다. PCR 검사와 같은 첨단 진단법의 보급은 의사가 이전보다 더 신속하게 병원체를 특정할 수 있게 됨으로써, 뇌수막염의 검출 방법에 혁명을 가져왔습니다. 또한, 뇌수막염 관련 증상에 대한 인식 제고 캠페인을 통해 더 많은 사람들이 의료 도움을 구하게 되면서, 이 부문에서 시장 기회가 창출되고 있습니다.
목차
제1장 수막염 진단 검사 시장 개요
제2장 주요 요약
제3장 수막염 진단 검사 주요 시장 동향
제4장 수막염 진단 검사 산업 분석
제5장 수막염 진단 검사 시장 : 높아지는 지정학적 긴장의 영향
제6장 수막염 진단 검사 시장 구도
제7장 수막염 진단 검사 시장 : 테스트 유형별
제8장 수막염 진단 검사 시장 : 기술별
제9장 수막염 진단 검사 시장 : 샘플 유형별
제10장 수막염 진단 검사 시장 : 병원체별
제11장 수막염 진단 검사 시장 : 최종사용자별
제12장 수막염 진단 검사 시장 : 지역별
제13장 주요 벤더 분석 : 수막염 진단 검사 산업
제14장 AnalystView의 전방위 전망
KSM 26.06.30Meningitis Diagnostic Testing Market size was valued at US$ 128.98 Million in 2025, expanding at a CAGR of 3.5% from 2026 to 2033.
Meningitis diagnostic testing can be defined as the process of conducting diagnostic examinations for determining whether a person has an infection involving the inflammation of the meninges, which are the protective layers around the brain and spinal cord. Meningitis tests include those that help determine the causative agents that trigger the condition so that the patient can be put under effective treatment. Some of the tests conducted as part of meningitis diagnosis include CSF analysis, blood culture, PCR tests, antigen tests, microscopic examination, and molecular methods. The major reason for conducting such tests is to ensure accurate diagnosis and early medical intervention for minimizing the adverse effects associated with the condition. As a result of the increasing importance of disease detection and monitoring, meningitis diagnostic testing has become essential in the modern health care system and institutions across the world.
Meningitis Diagnostic Testing Market- Market Dynamics
Advancements in nanotechnology and microfabrication to propel market demand
The rise in numbers of patients diagnosed with meningitis across the world represents a significant factor that positively affects the development of the Meningitis Diagnostic Testing market due to the need to diagnose this disease timely in order to treat it in a timely manner. Meningitis is a significant health issue due to its high levels of mortality and morbidity, along with some possible outcomes related to brain damage caused by this disease. According to WHO, meningitis continues to represent an urgent health challenge across the globe, being widespread in poor countries as well as in the African meningitis belt. Some official statistics confirm this problem. For instance, as stated in reports provided by WHO, every year, approximately 2.5 million people get infected with meningitis, including 1.6 million who have bacterial meningitis and 240,000 deaths annually. What is more, approximately 20% of patients have some serious disabilities related to hearing impairment, memory losses, and even brain complications. WHO developed its global strategy aimed at fighting with meningitis until 2030.
Meningitis Diagnostic Testing Market- Segmentation Analysis:
The Global Meningitis Diagnostic Testing Market is segmented on the basis of Test Type, Technology, Sample Type, Pathogen, End-User, and Region.
The market is divided into six categories based on test type: Latex Agglutination Tests, PCR Assay, Lateral-Flow Assay, CRISPR-based Assay, Culture Test and ELISA Tests. The PCR Assay are likely to dominates the meningitis diagnostic testing market. It is attributed to the capability of offering fast, precise, and accurate identification of pathogens that cause meningitis. The PCR assay identifies bacteria, virus, or fungi present within CSF or other sample types collected from patients with the disease. There is a growing need to identify meningitis pathogens early enough to allow prompt diagnosis and initiation of treatment, especially when patients are at risk of death from the disease.
The market is divided into four categories based on pathogen: Bacterial, Fungal, Parasitic and Viral. The bacterial might be holding a majority of market share. This increase may be associated with the significant effects of bacterial infections on the health of patients, as well as the need for accurate and fast diagnostics. Bacterial meningitis is characterized by very high levels of risk both regarding mortality and morbidity, with such complications as hearing loss, brain damage, and intellectual disability sometimes developing due to the development of this disease. There has been a great increase in cases of bacterial infection from Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae, which necessitates innovative technologies for diagnosing diseases.
Meningitis Diagnostic Testing Market- Geographical Insights
North America is likely to lead the meningitis diagnostic testing market. Its growth can be attributed to the fact that it possesses superior health care infrastructure, extensive application of molecular diagnostic techniques, and a highly focused approach towards infectious diseases surveillance. The North America region has been benefiting from extensive health care networks, advanced clinical laboratories, and extensive research & development activities in the field of health care, which contribute towards the efficient diagnosis and management of meningitis patients. Increased awareness on the part of the health care practitioners about the importance of early diagnosis along with the availability of advanced diagnostic tests like polymerase chain reaction tests, multiplex molecular diagnostic panels, and automated laboratories is boosting the volumes of diagnostic tests performed in the region. Furthermore, the health organizations like CDC and PHAC monitor meningitis cases and support vaccine programs and disease surveillance initiatives, which has resulted in an increased demand for meningitis diagnostic tests.
US Meningitis Diagnostic Testing Market- Country Insights
In the region, the US might be capturing the largest market share. Growth in the sector has been supported by ongoing advancements in technology. Availability of high-tech diagnostics like PCR testing has revolutionized the way doctors detect meningitis as they can now identify pathogens more quickly than before. Moreover, awareness campaigns about the symptoms linked to meningitis have urged more people to seek medical assistance, thus creating opportunities for the market in this segment.
Meningitis Diagnostic Testing Market- Competitive Landscape:
The meningitis diagnostic testing market is known for its high level of competition involving international diagnostic service providers, molecular diagnostic technology suppliers, clinical laboratories solutions makers, and biotechnological firms. Main competitive drivers include technical innovation, accuracy, speed of the procedure, portfolio diversity, regulatory approval, and distribution on an international level. Currently, many participants are making efforts aimed at developing cutting-edge molecular diagnostic systems, multiplex PCR kits, rapid antigen detection tests, and automated laboratory solutions that would allow identifying pathogens responsible for meningitis much faster and with higher precision. Increasing demand for quick diagnosis of meningitis contributes to greater spending on R&D.
Recent Developments:
In February 2024, QIAGEN announced the launch of two syndromic testing panels for its QIAstat-Dx instruments in India, including the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, which join the Respiratory SARS-CoV-2 Panel that had been authorized for emergency use in 2020 first time. The panels have received regulatory approval from the Central Drugs Standard Control Organization (CDSCO), enabling healthcare providers in India to diagnose patients accurately, faster, and easier.
In September 2024, Thermo Fisher Scientific announced the expansion of its bioanalytical laboratory services in Europe. This initiative aimed to enhance its capabilities in supporting the growing demand for bioanalytical testing across various sectors, including pharmaceuticals and biotechnology. The expansion included the addition of state-of-the-art technologies and an increase in laboratory capacity, which positioned the company to serve its clients better and improve turnaround times for critical testing services.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- QIAGEN N.V.
- BD
- Hologic Inc.
- Bio-Rad Laboratories
- Seegene Inc.
- ELITechGroup
- F. Hoffmann-La Roche Ltd.
- GenMark Diagnostics
- bioMerieux
- IMMY
- DiaSorin S.p.A.
- Oxford Nanopore Technologies
- Abbott
- Danaher
- Siemens Healthineers
- Thermo Fisher Scientific
- Trinity Biotech
- Tosoh Corporation
- Meridian Bioscience
- Quanterix Corporation
- Others
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033
- Latex Agglutination Tests
- PCR Assay
- Lateral-Flow Assay
- CRISPR-based Assay
- Culture Test
- ELISA Tests
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Molecular Diagnostics
- Microbiology/Culture
- Immunoassays
- Next-Generation Sequencing
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033
- Cerebrospinal Fluid (CSF)
- Nasopharyngeal Swab
- Blood/Serum
- Others
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY PATHOGEN- MARKET ANALYSIS, 2020 - 2033
- Bacterial
- Fungal
- Parasitic
- Viral
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Academic & Research Labs
- Diagnostic Centers
- Others
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Meningitis Diagnostic Testing Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Meningitis Diagnostic Testing Market Snippet by Test Type
- 2.1.2. Meningitis Diagnostic Testing Market Snippet by Technology
- 2.1.3. Meningitis Diagnostic Testing Market Snippet by Sample Type
- 2.1.4. Meningitis Diagnostic Testing Market Snippet by Pathogen
- 2.1.5. Meningitis Diagnostic Testing Market Snippet by End-User
- 2.1.6. Meningitis Diagnostic Testing Market Snippet by Country
- 2.1.7. Meningitis Diagnostic Testing Market Snippet by Region
- 2.2. Competitive Insights
3. Meningitis Diagnostic Testing Key Market Trends
- 3.1. Meningitis Diagnostic Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Meningitis Diagnostic Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Meningitis Diagnostic Testing Market Opportunities
- 3.4. Meningitis Diagnostic Testing Market Future Trends
4. Meningitis Diagnostic Testing Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Meningitis Diagnostic Testing Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Meningitis Diagnostic Testing Market Landscape
- 6.1. Meningitis Diagnostic Testing Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Meningitis Diagnostic Testing Market - By Test Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Test Type, 2025 & 2033 (%)
- 7.1.2. Latex Agglutination Tests
- 7.1.3. PCR Assay
- 7.1.4. Lateral-Flow Assay
- 7.1.5. CRISPR-based Assay
- 7.1.6. Culture Test
- 7.1.7. ELISA Tests
8. Meningitis Diagnostic Testing Market - By Technology
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
- 8.1.2. Molecular Diagnostics
- 8.1.3. Microbiology/Culture
- 8.1.4. Immunoassays
- 8.1.5. Next-Generation Sequencing
9. Meningitis Diagnostic Testing Market - By Sample Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Sample Type, 2025 & 2033 (%)
- 9.1.2. Cerebrospinal Fluid (CSF)
- 9.1.3. Nasopharyngeal Swab
- 9.1.4. Blood/Serum
- 9.1.5. Others
10. Meningitis Diagnostic Testing Market - By Pathogen
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Pathogen, 2025 & 2033 (%)
- 10.1.2. Bacterial
- 10.1.3. Fungal
- 10.1.4. Parasitic
- 10.1.5. Viral
11. Meningitis Diagnostic Testing Market - By End-User
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By End-User, 2025 & 2033 (%)
- 11.1.2. Hospitals
- 11.1.3. Academic & Research Labs
- 11.1.4. Diagnostic Centers
- 11.1.5. Others
12. Meningitis Diagnostic Testing Market- By Geography
- 12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 12.2. North America
- 12.2.1. Overview
- 12.2.2. Meningitis Diagnostic Testing Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
- 12.2.9.1. Overview
- 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.2.9.3. U.S. Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.9.5. U.S. Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.2.9.6. U.S. Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.2.9.7. U.S. Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
- 12.2.10.1. Overview
- 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.2.10.3. Canada Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.2.10.5. Canada Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.2.10.6. Canada Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.2.10.7. Canada Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3. Europe
- 12.3.1. Overview
- 12.3.2. Meningitis Diagnostic Testing Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
- 12.3.9.1. Overview
- 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.9.3. Germany Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.9.5. Germany Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.9.6. Germany Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.9.7. Germany Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
- 12.3.10.1. Overview
- 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.10.3. UK Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.10.5. UK Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.10.6. UK Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.10.7. UK Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.11. France
- 12.3.11.1. Overview
- 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.11.3. France Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.11.5. France Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.11.6. France Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.11.7. France Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
- 12.3.12.1. Overview
- 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.12.3. Italy Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.12.5. Italy Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.12.6. Italy Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.12.7. Italy Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
- 12.3.13.1. Overview
- 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.13.3. Spain Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.13.5. Spain Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.13.6. Spain Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.13.7. Spain Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
- 12.3.14.1. Overview
- 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.14.3. The Netherlands Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.14.5. The Netherlands Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.14.6. The Netherlands Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.14.7. The Netherlands Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
- 12.3.15.1. Overview
- 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.15.3. Sweden Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.15.5. Sweden Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.15.6. Sweden Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.15.7. Sweden Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
- 12.3.16.1. Overview
- 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.16.3. Russia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.16.5. Russia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.16.6. Russia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.16.7. Russia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
- 12.3.17.1. Overview
- 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.17.3. Poland Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.17.5. Poland Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.17.6. Poland Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.17.7. Poland Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.3.18. Rest of Europe
- 12.3.18.1. Overview
- 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.3.18.3. Rest of the Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.3.18.5. Rest of the Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.18.6. Rest of the Europe Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.3.18.7. Rest of the Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Meningitis Diagnostic Testing Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.9. China
- 12.4.9.1. Overview
- 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.9.3. China Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.9.5. China Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.9.6. China Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.9.7. China Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.10. India
- 12.4.10.1. Overview
- 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.10.3. India Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.10.5. India Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.10.6. India Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.10.7. India Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
- 12.4.11.1. Overview
- 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.11.3. Japan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.11.5. Japan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.11.6. Japan Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.11.7. Japan Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
- 12.4.12.1. Overview
- 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.12.3. South Korea Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.12.5. South Korea Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.12.6. South Korea Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.12.7. South Korea Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
- 12.4.13.1. Overview
- 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.13.3. Australia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.13.5. Australia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.13.6. Australia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.13.7. Australia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
- 12.4.14.1. Overview
- 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.14.3. Indonesia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.14.5. Indonesia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.14.6. Indonesia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.14.7. Indonesia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
- 12.4.15.1. Overview
- 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.15.3. Thailand Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.15.5. Thailand Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.15.6. Thailand Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.15.7. Thailand Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
- 12.4.16.1. Overview
- 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.16.3. Philippines Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.16.5. Philippines Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.16.6. Philippines Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.16.7. Philippines Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.4.17. Rest of APAC
- 12.4.17.1. Overview
- 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.4.17.3. Rest of APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.4.17.5. Rest of APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.17.6. Rest of APAC Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.4.17.7. Rest of APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Meningitis Diagnostic Testing Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
- 12.5.9.1. Overview
- 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.9.3. Brazil Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.9.5. Brazil Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.5.9.6. Brazil Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.5.9.7. Brazil Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
- 12.5.10.1. Overview
- 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.10.3. Mexico Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.10.5. Mexico Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.5.10.6. Mexico Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.5.10.7. Mexico Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
- 12.5.11.1. Overview
- 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.11.3. Argentina Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.11.5. Argentina Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.5.11.6. Argentina Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.5.11.7. Argentina Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
- 12.5.12.1. Overview
- 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.12.3. Colombia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.12.5. Colombia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.5.12.6. Colombia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.5.12.7. Colombia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
- 12.5.13.1. Overview
- 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.5.13.3. Rest of LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.5.13.5. Rest of LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.5.13.6. Rest of LATAM Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Meningitis Diagnostic Testing Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
- 12.6.9.1. Overview
- 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.9.3. Saudi Arabia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.9.5. Saudi Arabia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.9.6. Saudi Arabia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
- 12.6.10.1. Overview
- 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.10.3. United Arab Emirates Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.10.5. United Arab Emirates Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.10.6. United Arab Emirates Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
- 12.6.11.1. Overview
- 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.11.3. Israel Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.11.5. Israel Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.11.6. Israel Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.6.11.7. Israel Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
- 12.6.12.1. Overview
- 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.12.3. Turkey Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.12.5. Turkey Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.12.6. Turkey Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.6.12.7. Turkey Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
- 12.6.13.1. Overview
- 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.13.3. Algeria Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.13.5. Algeria Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.13.6. Algeria Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.6.13.7. Algeria Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
- 12.6.14.1. Overview
- 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.14.3. Egypt Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.14.5. Egypt Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.14.6. Egypt Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.6.14.7. Egypt Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
- 12.6.15. Rest of MEA
- 12.6.15.1. Overview
- 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 12.6.15.3. Rest of MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
- 12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 12.6.15.5. Rest of MEA Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.15.6. Rest of MEA Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
- 12.6.15.7. Rest of MEA Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Meningitis Diagnostic Testing Industry
- 13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
- 13.2. Company Profiles
- 13.2.1. QIAGEN N.V.
- 13.2.2. BD
- 13.2.3. Hologic Inc.
- 13.2.4. Bio-Rad Laboratories
- 13.2.5. Seegene Inc.
- 13.2.6. ELITechGroup
- 13.2.7. F. Hoffmann-La Roche Ltd.
- 13.2.8. GenMark Diagnostics
- 13.2.9. bioMerieux
- 13.2.10. IMMY
- 13.2.11. DiaSorin S.p.A.
- 13.2.12. Oxford Nanopore Technologies
- 13.2.13. Abbott
- 13.2.14. Danaher
- 13.2.15. Siemens Healthineers
- 13.2.16. Thermo Fisher Scientific
- 13.2.17. Trinity Biotech
- 13.2.18. Tosoh Corporation
- 13.2.19. Meridian Bioscience
- 13.2.20. Quanterix Corporation
- 13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
- 15.1. Research Methodology
- 15.2. References
- 15.3. Abbreviations
- 15.4. Disclaimer
- 15.5. Contact Us
